» Articles » PMID: 33898084

Impact of Tissue Heterogeneity Correction on Gamma Knife Stereotactic Radiosurgery of Acoustic Neuromas

Overview
Date 2021 Apr 26
PMID 33898084
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose/objectives: Treatment planning systems (TPS) for Gamma Knife stereotactic radiosurgery (GK-SRS) include TMR10 algorithms, which assumes tissue homogeneity equivalent to water, and collapsed-cone convolutional (CCC) algorithms, which accounts for tissue inhomogeneity. This study investigated dosimetric differences between TMR10 and CCC TPS for acoustic neuromas (ANs) treated with GK-SRS.

Materials/methods: A retrospective review of 56 AN treated with GK-SRS was performed. All patients underwent MRI and CT imaging during their initial treatment and were planned using TMR10. Each plan was recalculated with CCC using electron density extracted from CT. Parameters of interest included D, D, D, cochlea D, mean cochlea dose, target size, and laterality (>20 mm from central axis).

Results: Median target volume of patients was 1.5 cc (0.3 cc-2.8 cc) with median dose of 12 Gy prescribed to the 50% isodose line. Compared to CCC algorithms, the TMR10 calculated dose was higher: D was higher by an average 6.2% (p < 0.001), D was higher by an average 3.1% (p < 0.032), D was higher by an average of 11.3%. For lateralized targets, calculated D and D were higher by 7.1% (p < 0.001) and 10.6% (p < 0.001), respectively. For targets <1 cc, D and D were higher by 8.9% (p ≤ 0.009) and 12.1% (p ≤ 0.001), respectively. Cochlea D was higher, by an average of 20.1% (p < 0.001).

Conclusion: There was a statistically significant dosimetric differences observed between TMR10 and CCC algorithms for AN GK-SRS, particularly in small and lateralized ANs. It may be important to note these differences when relating GK-SRS with standard heterogeneity-corrected SRS regimens.

Citing Articles

Adaptation of dose-prescription for vestibular schwannoma radiosurgery taking body contouring method and heterogeneous material into account.

Fager M, Gubanski M, Carlsson Tedgren A, Benmakhlouf H Acta Oncol. 2025; 64:319-325.

PMID: 40008908 PMC: 11884334. DOI: 10.2340/1651-226X.2025.41924.


Zap-X Radiosurgery System: Initial Clinical Experience in a Recurrent Gamma Knife Case Series.

Horiba A, Hayashi M, Maruyama T, Nomura R, Kim P, Kawamata T Cureus. 2024; 16(11):e74005.

PMID: 39712764 PMC: 11660191. DOI: 10.7759/cureus.74005.

References
1.
Boari N, Bailo M, Gagliardi F, Franzin A, Gemma M, Vecchio A . Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg. 2014; 121 Suppl:123-42. DOI: 10.3171/2014.8.GKS141506. View

2.
Shields L, Bond C, Odom A, Sun D, Spalding A . Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study. Radiat Oncol. 2015; 10:193. PMC: 4574166. DOI: 10.1186/s13014-015-0500-y. View

3.
Kondziolka D, Lunsford L, McLaughlin M, Flickinger J . Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med. 1998; 339(20):1426-33. DOI: 10.1056/NEJM199811123392003. View

4.
Solberg T, Holly F, de Salles A, WALLACE R, Smathers J . Implications of tissue heterogeneity for radiosurgery in head and neck tumors. Int J Radiat Oncol Biol Phys. 1995; 32(1):235-9. DOI: 10.1016/0360-3016(94)00495-7. View

5.
Xiao Y, Papiez L, Paulus R, Timmerman R, Straube W, Bosch W . Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009; 73(4):1235-42. PMC: 2911132. DOI: 10.1016/j.ijrobp.2008.11.019. View